Psoriasis

Recruiting

A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)

I6T-MC-AMAH - ClinicalTrials.gov - NCT03556202

The purpose of this study is to evaluate the long-term safety and maintenance of efficacy of mirikizumab in participants with moderate-to-severe plaque psoriasis.
How long will I be in the trial?
The study will last about 220 weeks and may include up to 23 visits.
Email
Recruiting

A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)

I6T-MC-AMAH - ClinicalTrials.gov - NCT03556202

The purpose of this study is to evaluate the long-term safety and maintenance of efficacy of mirikizumab in participants with moderate-to-severe plaque psoriasis.
How long will I be in the trial?
The study will last about 220 weeks and may include up to 23 visits.
Email

Key Requirements

Age :

18+

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must have completed the last visit of an eligible study period of originating study

Participants must be willing to follow the birth control measures during and after study treatment if woman of childbearing potential

Participants must NOT

Participants must not have an unstable or uncontrolled illness, including but not limited to a cerebro-cardiovascular, respiratory, liver, kidney, gastrointestinal, endocrine, blood, or neurologic disease or abnormal lab results, that the study investigator thinks makes it unsafe or inappropriate for the participant to participate in this study

Participants must not have stopped taking mirikizumab during a previous study if the study investigator does not think the participant should resume taking mirikizumab

Trial Summary

Conditions the trial is for

Psoriasis

What the trial is testing?

Mirikizumab

Could I receive a Placebo?

no

Enrollment Goal

1816

Trial Dates

September 2018 - May 2024

Trial Phase

3

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must have completed the last visit of an eligible study period of originating study

Participants must be willing to follow the birth control measures during and after study treatment if woman of childbearing potential

Participants must NOT

Participants must not have an unstable or uncontrolled illness, including but not limited to a cerebro-cardiovascular, respiratory, liver, kidney, gastrointestinal, endocrine, blood, or neurologic disease or abnormal lab results, that the study investigator thinks makes it unsafe or inappropriate for the participant to participate in this study

Participants must not have stopped taking mirikizumab during a previous study if the study investigator does not think the participant should resume taking mirikizumab

Trial Summary

Conditions the trial is for

Psoriasis

What the trial is testing?

Mirikizumab

Could I receive a Placebo?

no

Enrollment Goal

1816

Trial Dates

September 2018 - May 2024

Trial Phase

3

Not the right fit? Sign up to receive updates on new Psoriasis trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Psoriasis Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?